Paul Whelton

Q: What Schools Are Affiliated With Paul Whelton

Paul Whelton is affiliated with the following schools: Icahn School of Medicine at Mount Sinai, Loyola University Chicago, University of Texas Health Science Center at Houston, Johns Hopkins University, Yonsei University, New York University, Federal University of Rio Grande do Sul, Tulane University

Paul Whelton's AcademicInfluence.com Rankings

Paul Whelton

Medical

#447

World Rank

#615

Historical Rank

Public Health

#65

World Rank

#67

Historical Rank

medical Degrees

Paul Whelton

Philosophy

#2945

World Rank

#4880

Historical Rank

Logic

#907

World Rank

#1477

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Why Is Paul Whelton Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Paul Kieran Whelton is an Irish-born American physician and scientist who has contributed to the fields of hypertension and kidney disease epidemiology. He also mentored several public health leaders including the deans of the schools of public health at Johns Hopkins and Columbia . He currently serves as the Show Chwan Health Care System Endowed Chair in Global Public Health and a Clinical Professor in the Department of Epidemiology at the Tulane University School of Public Health and Tropical Medicine. He is the founding director of the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University.

(See a Problem?)

Paul Whelton's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Global burden of hypertension: analysis of worldwide data (2005) (7893)
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2002) (5253)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) (3162)
Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. (1995) (3113)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (2627)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (2375)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019 (2020) (2362)
Blood pressure and end-stage renal disease in men. (1996) (1646)
Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. (2002) (1518)
Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. (1995) (1329)
The Metabolic Syndrome and Chronic Kidney Disease in U.S. Adults (2004) (1303)
Worldwide prevalence of hypertension: a systematic review (2004) (1249)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (1199)
Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP) (2007) (1196)
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. (2001) (1181)
Major causes of death among men and women in China. (2005) (1160)
Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. (1998) (1159)
Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. (2002) (1050)
Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial. (2016) (924)
Prevalence of the metabolic syndrome and overweight among adults in China (2005) (903)
Trends in blood pressure among children and adolescents. (2004) (882)
Epidemiology of hypertension (1994) (860)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (854)
Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical trials. (1997) (844)
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. (2002) (832)
Effects of Alcohol Reduction on Blood Pressure: A Meta-Analysis of Randomized Controlled Trials (2001) (774)
The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention, Phase I. (1992) (722)
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial (2019) (639)
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. (1999) (624)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2017) (610)
Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline (2018) (606)
Prevalence, Awareness, Treatment, and Control of Hypertension in China (2002) (594)
End-stage renal disease in African-American and white men. 16-year MRFIT findings. (1997) (590)
Rationale and Design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (1996) (573)
Serum cholesterol in young men and subsequent cardiovascular disease. (1993) (549)
Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. (1999) (518)
Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials. (1998) (509)
Does supplementation of diet with 'fish oil' reduce blood pressure? A meta-analysis of controlled clinical trials. (1993) (488)
Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. (2000) (455)
Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. (1994) (451)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (439)
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality: A Systematic Review and Network Meta-analysis (2017) (437)
Effect of dietary fiber intake on blood pressure: a meta-analysis of randomized, controlled clinical trials (2005) (422)
The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease (2004) (412)
Relationship between Cigarette Smoking and Novel Risk Factors for Cardiovascular Disease in the United States (2003) (411)
Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the Trials of Hypertension Prevention follow-up study. (2009) (409)
Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) (2003) (400)
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: The Systolic Blood Pressure Intervention Trial (SPRINT) (2014) (398)
Sodium, Blood Pressure, and Cardiovascular Disease: Further Evidence Supporting the American Heart Association Sodium Reduction Recommendations (2012) (387)
Insulin resistance and risk of chronic kidney disease in nondiabetic US adults. (2003) (378)
High Blood Pressure and Cardiovascular Disease (2019) (372)
Alcohol Consumption and the Incidence of Hypertension: The Atherosclerosis Risk in Communities Study (2001) (363)
Body weight and mortality among men and women in China. (2006) (350)
Legume consumption and risk of coronary heart disease in US men and women: NHANES I Epidemiologic Follow-up Study. (2001) (350)
Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. (1999) (335)
Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2005) (328)
Effects of Intensive BP Control in CKD. (2017) (320)
Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. (2000) (314)
Relation Between Blood Pressure and Renin, Renin Substrate, Angiotensin II, Aldosterone and Urinary Sodium and Potassium in 574 Ambulatory Subjects (1979) (300)
New guidelines for potassium replacement in clinical practice: a contemporary review by the National Council on Potassium in Clinical Practice. (2000) (280)
Dietary fiber intake and reduced risk of coronary heart disease in US men and women: the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. (2003) (273)
Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline (2018) (272)
The effect of chronic coffee drinking on blood pressure: a meta-analysis of controlled clinical trials. (1999) (272)
Risk of End-stage Renal Disease in Diabetes Mellitus: A Prospective Cohort Study of Men Screened for MRFIT (1997) (271)
Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2006) (271)
Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril (2005) (270)
Epidemiology and the Prevention of Hypertension (1997) (267)
Coffee consumption and serum lipids: a meta-analysis of randomized controlled clinical trials. (2001) (261)
Effects of low-carbohydrate and low-fat diets: a randomized trial. (2014) (260)
Factors associated with hypertension control in the general population of the United States. (2002) (254)
Meta-analysis of observational studies on fish intake and coronary heart disease. (2004) (253)
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2005) (248)
Weight-loss experience of black and white participants in NHLBI-sponsored clinical trials. (1991) (247)
Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril. (2005) (244)
Prevalence of Cardiovascular Disease Risk Factor Clustering Among the Adult Population of China: Results From the International Collaborative Study of Cardiovascular Disease in Asia (InterAsia) (2005) (243)
Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. (1997) (242)
Methodological Issues in Cohort Studies That Relate Sodium Intake to Cardiovascular Disease Outcomes: A Science Advisory From the American Heart Association (2014) (238)
Metabolic syndrome and salt sensitivity of blood pressure in non-diabetic people in China: a dietary intervention study (2009) (233)
Potential U.S. Population Impact of the 2017 American College of Cardiology/American Heart Association High Blood Pressure Guideline (2017) (232)
Hypertension prevalence, awareness, treatment, and control in Egypt. Results from the Egyptian National Hypertension Project (NHP). NHP Investigative Team. (1995) (225)
Lower Levels of Sodium Intake and Reduced Cardiovascular Risk (2013) (223)
Prevalence and Risk Factors of Overweight and Obesity in China (2007) (223)
Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality (2015) (220)
Cardiovascular Outcomes in High-Risk Hypertensive Patients Stratified by Baseline Glomerular Filtration Rate (2006) (217)
The excess incidence of diabetic end-stage renal disease among blacks. A population-based study of potential explanatory factors. (1992) (216)
Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. (2005) (215)
End-Stage Renal Disease Attributable to Diabetes Mellitus (1994) (213)
Prevention and Control of Hypertension: JACC Health Promotion Series. (2018) (211)
Association of Intensive vs Standard Blood Pressure Control With Cerebral White Matter Lesions. (2019) (207)
Race and end-stage renal disease. Socioeconomic status and access to health care as mediating factors. (1995) (205)
Effects of Oral Potassium on Blood Pressure: Meta-Analysis of Randomized Controlled Clinical Trials (1998) (204)
Effect of Soybean Protein on Blood Pressure: A Randomized, Controlled Trial (2005) (199)
Stroke in the People's Republic of China. I. Geographic variations in incidence and risk factors. (1995) (194)
Serum Total and Lipoprotein Cholesterol Levels and Awareness, Treatment, and Control of Hypercholesterolemia in China (2004) (189)
Trends in pharmacologic management of hypertension in the United States. (1995) (188)
Gender difference in blood pressure responses to dietary sodium intervention in the GenSalt study (2009) (185)
Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. (1991) (184)
Premature deaths attributable to blood pressure in China: a prospective cohort study (2009) (182)
Risk of stroke in male cigarette smokers. (1987) (182)
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis (2021) (181)
Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension: trials of hypertension prevention, phase II. (1998) (179)
Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? (1991) (174)
Blood Pressure Measurement in SPRINT (Systolic Blood Pressure Intervention Trial) (2018) (170)
Familial aggregation of renal disease in a population-based case-control study. (1998) (167)
Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia (2004) (166)
Stroke in the People's Republic of China. II. Meta-analysis of hypertension and risk of stroke. (1995) (165)
Clinical Events in High-Risk Hypertensive Patients Randomly Assigned to Calcium Channel Blocker Versus Angiotensin-Converting Enzyme Inhibitor in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (2006) (165)
Dietary sodium intake and incidence of congestive heart failure in overweight US men and women: first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. (2002) (165)
Potential U.S. Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline. (2018) (165)
Effect of dietary fiber and protein intake on blood pressure: a review of epidemiologic evidence. (1999) (163)
Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. (2016) (163)
Prevalence of decreased kidney function in Chinese adults aged 35 to 74 years. (2005) (163)
The association of skin color with blood pressure in US blacks with low socioeconomic status. (1991) (161)
Association between the metabolic syndrome and chronic kidney disease in Chinese adults. (2007) (160)
Dietary Intake of Folate and Risk of Stroke in US Men and Women: NHANES I Epidemiologic Follow-Up Study (2002) (153)
Oats and buckwheat intakes and cardiovascular disease risk factors in an ethnic minority of China. (1995) (153)
Cigarette smoking and exposure to environmental tobacco smoke in China: the international collaborative study of cardiovascular disease in Asia. (2004) (151)
Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal Disease: Results From the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (150)
Elevated systolic blood pressure as a risk factor for cardiovascular and renal disease. (1999) (149)
Vitamin C status and mortality in US adults. (2000) (149)
Hypertension as a Risk Factor for Renal Disease Review of Clinical and Epidemiological Evidence (1989) (148)
Geographic variations in the prevalence, awareness, treatment and control of hypertension in China (2003) (146)
Diabetes mellitus, race, and socioeconomic status. A population-based study. (1996) (143)
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. (2018) (141)
Decline in US stroke mortality. Demographic trends and antihypertensive treatment. (1989) (139)
Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. (2006) (139)
Factors Associated With Hypertension Awareness, Treatment, and Control in a Representative Sample of the Chinese Population (2004) (138)
Blood Lead Level Is Associated With Elevated Blood Pressure in Blacks (2003) (137)
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. (1996) (136)
A prospective study of blood pressure and serum creatinine. Results from the 'Clue' Study and the ARIC Study. (1993) (136)
Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III). (2004) (134)
Etiologic factors in renovascular fibromuscular dysplasia. A case-control study. (1989) (134)
Effect of dietary fiber intake on blood pressure: a randomized, double-blind, placebo-controlled trial (2004) (131)
Association between inflammation and insulin resistance in U.S. nondiabetic adults: results from the Third National Health and Nutrition Examination Survey. (2004) (131)
Echocardiographic Identification of Cardiovascular Sources of Emboli To Guide Clinical Management of Stroke: A Cost-Effectiveness Analysis (1997) (128)
Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. (1989) (127)
Risk of end-stage renal disease associated with alcohol consumption. (1999) (126)
Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. (1998) (123)
Dietary Potassium Intake and Risk of Stroke in US Men and Women: National Health and Nutrition Examination Survey I Epidemiologic Follow-Up Study (2001) (120)
Body mass and blood pressure in a lean population in southwestern China. (1994) (117)
Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control (2018) (116)
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. (2021) (112)
Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly. (2002) (109)
Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. (2008) (108)
Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (2008) (108)
Serum Antioxidant Vitamins and Blood Pressure in the United States Population (2002) (103)
Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. (1997) (102)
Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension (2007) (100)
Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. (1998) (99)
Erratum: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: Data from the health examination surveys. 1960-1991 (Hypertension (1995) 26 (60-69)) (1996) (95)
SPRINT Trial Results: Latest News in Hypertension Management. (2016) (95)
Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II (2005) (94)
Prevalence of Apparent Treatment-Resistant Hypertension in the United States: Comparison of the 2008 and 2018 American Heart Association Scientific Statements on Resistant Hypertension (2019) (92)
Diagnosis of hypertensive end-stage renal disease: effect of patient's race. (1995) (92)
Primary prevention of essential hypertension. (2004) (92)
Hypertension Subtype and Risk of Cardiovascular Disease in Chinese Adults (2007) (91)
Increasing prevalence and low awareness, treatment and control of diabetes mellitus among Chinese adults: the InterASIA study. (2008) (91)
A randomized controlled trial of dietary fiber intake on serum lipids (2006) (89)
The International Consortium for Quality Research on Dietary Sodium/Salt (TRUE) position statement on the use of 24‐hour, spot, and short duration (<24 hours) timed urine collections to assess dietary sodium intake (2019) (88)
Awareness, use, and impact of the 1984 Joint National Committee consensus report on high blood pressure. (1988) (88)
Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel. (2019) (85)
ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. (2009) (82)
Blood Pressure Control by Drug Group in the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2008) (82)
Effect of Blood Pressure on Early Decline in Kidney Function Among Hypertensive Men (2003) (81)
Combinations of potassium, calcium, and magnesium supplements in hypertension. (1995) (81)
Effect of dietary protein supplementation on blood pressure: a randomized, controlled trial. (2011) (81)
Effect of potassium supplementation on blood pressure in African Americans on a low-potassium diet. A randomized, double-blind, placebo-controlled trial. (1996) (81)
The 2017 Clinical Practice Guideline for High Blood Pressure. (2017) (80)
Effect of potassium supplementation on blood pressure in Chinese: a randomized, placebo-controlled trial (2001) (80)
Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial. (2017) (76)
The role of blood pressure as a risk factor for renal disease: a review of the epidemiologic evidence. (1996) (76)
Trial of Nonpharmacologic Intervention in the Elderly (TONE). Design and rationale of a blood pressure control trial. (1995) (75)
The 2018 European Society of Cardiology/European Society of Hypertension and 2017 American College of Cardiology/American Heart Association Blood Pressure Guidelines: More Similar Than Different. (2018) (74)
Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO) (2015) (74)
Projections of hypertension-related renal disease in middle-aged residents of the United States. (1993) (74)
The elusiveness of population-wide high blood pressure control. (2015) (73)
The technical report on sodium intake and cardiovascular disease in low- and middle-income countries by the joint working group of the World Heart Federation, the European Society of Hypertension and the European Public Health Association. (2017) (72)
Research Needs to Improve Hypertension Treatment and Control in African Americans (2016) (72)
Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials. (2018) (72)
Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR. (2012) (72)
Cigarette smoking and erectile dysfunction among Chinese men without clinical vascular disease. (2007) (71)
Long-Term Effects of Incident Diabetes Mellitus on Cardiovascular Outcomes in People Treated for Hypertension: The ALLHAT Diabetes Extension Study (2012) (70)
Prevalence of cardiovascular risk factors in South Korean adults: results from the Korea Medical Insurance Corporation (KMIC) Study. (1998) (69)
Cause of death in patients with end-stage renal disease: death certificates vs registry reports. (1993) (69)
Blood pressure and risk of cardiovascular disease in Chinese men and women. (2008) (68)
Prehypertension and risk of cardiovascular disease in Chinese adults (2009) (68)
A population-based, prospective study of blood pressure and risk for end-stage renal disease in China. (2007) (67)
International collaborative study of cardiovascular disease in Asia: design, rationale, and preliminary results. (2004) (66)
Predictors and mediators of successful long-term withdrawal from antihypertensive medications. TONE Cooperative Research Group. Trial of Nonpharmacologic Interventions in the Elderly. (1999) (65)
Potassium Intake and Blood Pressure: A Dose‐Response Meta‐Analysis of Randomized Controlled Trials (2020) (65)
Potassium in preventing and treating high blood pressure. (1999) (64)
Central Rather Than Overall Obesity Is Related to Diabetes in the Chinese Population: The InterASIA Study (2007) (64)
Effect of soybean protein on novel cardiovascular disease risk factors: a randomized controlled trial (2013) (63)
Health effects of sodium and potassium in humans (2014) (63)
Effects of Intensive Systolic Blood Pressure Lowering on Cardiovascular Events and Mortality in Patients With Type 2 Diabetes Mellitus on Standard Glycemic Control and in Those Without Diabetes Mellitus: Reconciling Results From ACCORD BP and SPRINT (2018) (62)
The Impact of JNC-VI Guidelines on Treatment Recommendations in the US Population (2002) (62)
Dietary macronutrients and blood pressure in southwestern China (1995) (61)
Recruitment in the Trial of Nonpharmacologic Intervention in the Elderly (TONE) (1997) (61)
Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial) (2017) (61)
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis (2021) (60)
End-stage Renal Disease in African-American and White Men (2016) (60)
Standards for the Uniform Reporting of Hypertension in Adults Using Population Survey Data: Recommendations From the World Hypertension League Expert Committee (2014) (60)
End-stage renal disease in US minority groups. (1992) (60)
W. Gordon Walker, MD, FACP (2005) (59)
Sodium, Potassium, Blood Pressure, and Cardiovascular Disease in Humans (2014) (59)
Using Predicted Cardiovascular Disease Risk in Conjunction With Blood Pressure to Guide Antihypertensive Medication Treatment. (2017) (59)
Plasma insulin levels and incidence of hypertension in African Americans and whites. (1999) (59)
Recreational drug use: a neglected risk factor for end-stage renal disease. (2001) (59)
Undetected eye disease in a primary care clinic population. (1994) (58)
Antihypertensive Prescriptions for Newly Treated Patients Before and After the Main Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Results and Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure Guidel (2009) (57)
Epidemiology and prevention of blood pressure-related renal disease. (1992) (57)
Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER‐Prevention Randomized Clinical Trial (2016) (57)
Effect of migration and related environmental changes on serum lipid levels in southwestern Chinese men. (1996) (56)
The 2017 American College of Cardiology/American Heart Association Clinical Practice Guideline for High Blood Pressure in Adults. (2018) (56)
Urinary triclosan concentrations are inversely associated with body mass index and waist circumference in the US general population: Experience in NHANES 2003-2010. (2015) (54)
Percentage of ingested sodium excreted in 24‐hour urine collections: A systematic review and meta‐analysis (2018) (54)
The renin-angiotensin system and blood pressure: differences between blacks and whites. (1999) (54)
Hypertension Pharmacological Treatment in Adults: A World Health Organization Guideline Executive Summary (2021) (53)
Effect of Chlorthalidone, Amlodipine, and Lisinopril on Visit‐to‐Visit Variability of Blood Pressure: Results From the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2014) (53)
Agreement on nutrient intake between the databases of the First National Health and Nutrition Examination Survey and the ESHA Food Processor. (2002) (53)
Blood Pressure Effects of Sodium Reduction (2021) (53)
ALLHAT: Setting the Record Straight (2004) (52)
Impact of the ALLHAT/JNC7 Dissemination Project on thiazide-type diuretic use. (2010) (52)
Strategies for improvement of awareness, treatment and control of hypertension: results of a panel discussion (2004) (52)
Genetic variants in the renin–angiotensin–aldosterone system and salt sensitivity of blood pressure (2010) (52)
Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy: The Bogalusa Heart Study (2018) (51)
Prevalence and risk factors for type 2 diabetes mellitus in the Chinese adult population: the InterASIA Study. (2009) (51)
Baseline characteristics of participants in phase I of the Trials of Hypertension Prevention. (1992) (50)
Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients. (1994) (50)
Association of 3 Different Antihypertensive Medications With Hip and Pelvic Fracture Risk in Older Adults: Secondary Analysis of a Randomized Clinical Trial (2017) (50)
The effect of potassium supplementation in persons with a high-normal blood pressure. Results from phase I of the Trials of Hypertension Prevention (TOHP). Trials of Hypertension Prevention (TOHP) Collaborative Research Group. (1995) (48)
Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2005) (48)
The Effects of a Low-Carbohydrate Diet vs. a Low-Fat Diet on Novel Cardiovascular Risk Factors: A Randomized Controlled Trial (2015) (48)
The risk for mild kidney function decline associated with illicit drug use among hypertensive men. (2004) (44)
Cardiovascular risk factors in normotensive and hypertensive Egyptians (2001) (44)
Mortality and Morbidity During and After the Antihypertensive and Lipid‐Lowering Treatment to Prevent Heart Attack Trial (2012) (43)
Commentary: Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge (2002) (43)
Visit-to-Visit Variability of BP and CKD Outcomes: Results from the ALLHAT. (2016) (43)
Evaluation of screening schemes for eye disease in a primary care setting. (1998) (42)
São Paulo call to action for the prevention and control of high blood pressure: 2020 (2019) (42)
The contribution of urinary cations to the blood pressure differences associated with migration. (1995) (42)
Participant recruitment in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). (1998) (42)
History of hypertension in patients treated for end‐stage renal disease (1997) (42)
2017 ACC/AHA Blood Pressure Treatment Guideline Recommendations and Cardiovascular Risk. (2018) (41)
The production of dialysis by for-profit versus not-for-profit freestanding renal dialysis facilities. (1994) (41)
Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension (2021) (41)
Studying the causes of kidney disease in humans: a review of methodologic obstacles and possible solutions. (1995) (41)
Association of genetic variants in the apelin-APJ system and ACE2 with blood pressure responses to potassium supplementation: the GenSalt study. (2010) (40)
Chapter 23 – Blood Pressure Reduction (2004) (39)
Intensive vs Standard Blood Pressure Control in Adults 80 Years or Older: A Secondary Analysis of the Systolic Blood Pressure Intervention Trial (2019) (39)
Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline (2019) (38)
Short- and long-term prognosis after acute myocardial infarction in Chinese men and women. (1994) (37)
Hypertension Following Coronary Artery Bypass Surgery (1980) (37)
Treatment-Resistant Hypertension and the Incidence of Cardiovascular Disease and End-Stage Renal DiseaseNovelty and Significance (2014) (37)
Blood pressure levels and hypertension prevalence in a high selenium environment: results from a cross-sectional study. (2019) (37)
Agreement among indicators of vitamin C status. (1998) (37)
Kidney transplantation from living unrelated donors. (1992) (37)
A Comparison of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline and the 2017 American Diabetes Association Diabetes and Hypertension Position Statement for U.S. Adults With Diabetes (2018) (36)
Renal artery stenosis following transplantation: etiology, diagnosis, and prevention. (1978) (36)
Association of symptoms of depression and obesity with hypertension: the Bogalusa Heart Study. (2006) (36)
Epidemiology of high blood pressure. (1989) (36)
Hypertension following renal transplantation. Causative factors and therapeutic implications. (1979) (36)
Seven-year incidence of hypertension in a cohort of middle-aged African Americans and whites. (1998) (35)
Effect of Age on the Efficacy of Blood Pressure Treatment Strategies (1990) (35)
Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval. (1992) (35)
Concordance Between Blood Pressure in the Systolic Blood Pressure Intervention Trial and in Routine Clinical Practice. (2020) (34)
Dose–response of sodium excretion and blood pressure change among overweight, nonhypertensive adults in a 3-year dietary intervention study (2005) (34)
Selection of initial antihypertensive drug therapy (2000) (34)
The accuracy and precision of the Accutracker ambulatory blood pressure monitor. (1990) (33)
Implications of Early Decline in eGFR due to Intensive BP Control for Cardiovascular Outcomes in SPRINT. (2019) (33)
Early dosing practices and effectiveness of recombinant human erythropoietin. (1993) (33)
Effects of intensive versus standard blood pressure control on domain-specific cognitive function: a substudy of the SPRINT randomised controlled trial (2020) (33)
Benazepril plus amlodipine or hydrochlorothiazide for hypertension. (2009) (33)
Management of Stage 1 Hypertension in Adults With a Low 10-Year Risk for Cardiovascular Disease: Filling a Guidance Gap: A Scientific Statement From the American Heart Association. (2021) (33)
A trial of omega-3 fatty acids for prevention of hypertension. (2004) (33)
The effects of a low-carbohydrate diet on appetite: A randomized controlled trial. (2016) (31)
Alcohol consumption and blood pressure: a comparison of native Japanese to American men. (1990) (31)
What is the role of dietary sodium and potassium in hypertension and target organ injury? (1999) (31)
Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. (1996) (31)
Relation between Plasma Renin Activity, Angiotensin, and Aldosterone and Blood Pressure in Mild Untreated Hypertension (1976) (31)
The Egyptian National Hypertension Project (NHP). Design and rationale. The NHP Investigative Team. (1995) (30)
Agreement between overnight and 24-hour urinary cation excretions in southern Chinese men. (1993) (30)
Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: Results by Sex (2013) (30)
Monitoring and evaluation framework for hypertension programs. A collaboration between the Pan American Health Organization and World Hypertension League (2018) (30)
Vascular reactivity in young adults and cardiovascular disease. A prospective study. (1992) (30)
Rationale for Ambulatory and Home Blood Pressure Monitoring Thresholds in the 2017 American College of Cardiology/American Heart Association Guideline. (2019) (29)
Hypertension curriculum review: epidemiology and the prevention of hypertension. (2004) (29)
Alcohol use and blood pressure in an unacculturated society. (1993) (29)
History of myocardial infarction and stroke among incident end-stage renal disease cases and population-based controls: an analysis of shared risk factors. (2002) (29)
Urinary sodium and cardiovascular disease risk: informing guidelines for sodium consumption. (2011) (28)
Formal Public Health Education and Career Outcomes of Medical School Graduates (2012) (27)
Arterial and Venous Angiotensin II in Normal Subjects: Relation to Plasma Renin Activity and Plasma Aldosterone Concentration, and Response to Posture and Volume Changes (1976) (27)
Design, recruitment, and baseline characteristics of the EMPA-KIDNEY trial (2022) (27)
Passive cigarette smoking increases risk of coronary heart disease. (1999) (27)
A comparison of two automated monitors in the measurement of blood pressure reactivity. Trials of Hypertension Prevention Collaborative Research Group. (1990) (27)
The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture Risk (2017) (27)
Cigarette smoking and ESRD incidence in men screened for the MRFIT (1995) (27)
Physician approach to the recognition and initial management of hypertension. Results of a statewide survey of Maryland physicians. (1986) (27)
Relationship of serum antioxidant vitamins to serum creatinine in the US population. (2002) (26)
Analysis of sex hormone genes reveals gender differences in the genetic etiology of blood pressure salt sensitivity: the GenSalt study. (2013) (26)
Effect of soy and milk protein supplementation on serum lipid levels: a randomized controlled trial (2012) (26)
Characteristics and Long-Term Follow-Up of Participants with Peripheral Arterial Disease During ALLHAT (2014) (26)
Can We End the Salt Wars With a Randomized Clinical Trial in a Controlled Environment? (2018) (26)
The classics: a tribute to the fiftieth anniversary of the randomized clinical trial. (2000) (26)
An investigation of the relationship between stomach cancer and cerebrovascular disease: evidence for and against the salt hypothesis. (1982) (26)
Declining Mortality From Hypertension and Stroke (1982) (25)
Trajectories of childhood BMI and adult diabetes: the Bogalusa Heart Study (2018) (25)
Antihypertensive treatment and risk of cancer: an individual participant data meta-analysis (2021) (25)
Recommended treatment protocols to improve management of hypertension globally: A statement by Resolve to Save Lives and the World Hypertension League (WHL) (2018) (25)
[Prevalence, awareness, treatment and control of hypertension in Chinese adults]. (2003) (25)
Role of sodium reduction in the treatment and prevention of hypertension. (1997) (25)
Appointment attendance, pill counts, and achievement of goal blood pressure in the African American Study of Kidney Disease and Hypertension Pilot Study. (1996) (25)
Diuretic-induced hypokalemia and cardiac arrhythmias. (1986) (24)
Variability and rapid increase in body mass index during childhood are associated with adult obesity. (2015) (24)
27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 2. Clinical epidemiology: the conceptual basis for interpreting risk factors. (1996) (23)
PREVALENCE OF THE METABOLIC SYNDROME AMONG ADULTS IN CHINA: THE INTERNATIONAL COLLABORATIVE STUDY OF CARDIOVASCULAR DISEASE IN ASIA (INTERASIA) (2004) (23)
Genetic variants in the renin–angiotensin–aldosterone system and blood pressure responses to potassium intake (2011) (23)
Renin–angiotensin-system inhibitors and all-cause mortality in patients with COVID-19: a systematic review and meta-analysis of observational studies (2021) (23)
Evaluation of the Dinamap continuous blood pressure monitor. (1988) (23)
Surviving Hurricane Katrina: reconstructing the educational enterprise of Tulane University School of Medicine. (2007) (23)
Vision screening in a primary care setting. A missed opportunity? (1990) (23)
Treatment resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (23)
Salt intake, hypertension and risk of cardiovascular disease: an important public health challenge. (2002) (22)
Validity of 24-hour dietary recall interviews conducted among volunteers in an adult working community. (1995) (22)
A community-based evaluation of the Vita-Stat automatic blood pressure recorder. (1990) (22)
Rate of change in body mass index at different ages during childhood and adult obesity risk (2019) (22)
Implications of Recent Clinical Trials and Hypertension Guidelines on Stroke and Future Cerebrovascular Research (2018) (22)
Effectiveness of the Waksberg telephone sampling method for the selection of population controls. (1993) (22)
Getting clinical trial results into practice: design, implementation, and process evaluation of the ALLHAT Dissemination Project (2009) (22)
Neomycin toxicity revisited. (1976) (22)
Kidney damage in 'benign' essential hypertension (1997) (22)
Systemic hypertension, diuretic drugs, arrhythmias and death. (1985) (22)
Epidemiologic analysis of existing data to investigate hypertensive renal disease: an example from the Maryland End-Stage Renal Disease Registry. (1993) (21)
The decline in stroke mortality. An epidemiologic perspective. (1993) (21)
The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Resource for Practicing Clinicians (2018) (21)
Hypertension management in populations. (1993) (21)
Relationship between skin color and blood pressure in egyptian adults: results from the national hypertension project. (2000) (21)
Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trial (SPRINT): A Randomized Clinical Trial (2017) (21)
The impact of automated blood pressure devices on the efficiency of clinical trials. (1992) (21)
Antihypertensive Medication Use Among Recruits for the Trial of Nonpharmacologic Interventions in the Elderly (TONE) (1996) (20)
The Future of Clinical Trials in Chronic Renal Disease: Outcome of an NIH/FDA/Physician Specialist Conference (2000) (20)
The Relationship of Provider Organizational Status and Erythropoietin Dosing in End Stage Renal Disease Patients (1994) (20)
Sodium and Health: Old Myths and a Controversy Based on Denial (2022) (19)
Guidelines for blood pressure measurement: development over 30 years (2018) (19)
GLOBAL BURDEN OF HYPERTENSION: P 512 (2004) (19)
Interactions of genetic variants with physical activity are associated with blood pressure in Chinese: the GenSalt study. (2011) (19)
Dissociation of the diurnal variation of aldosterone and cortisol in anephric subjects. (1979) (19)
Blood Pressure Measurement: A KDOQI Perspective. (2019) (19)
Recruitment for phase I of the trials of hypertension prevention. (1993) (19)
The Influence of Baseline Diastolic Blood Pressure on the Effects of Intensive Blood Pressure Lowering on Cardiovascular Outcomes and All-Cause Mortality in Type 2 Diabetes (2020) (19)
ALLHAT: still providing correct answers after 7 years (2010) (18)
Evaluation of the Vita-Stat automatic blood pressure recorder. A comparison with the Random-Zero sphygmomanometer. (1983) (18)
Race and socioeconomic status in hypertension and renal disease. (1995) (18)
Exposure to Radiologic Contrast Media and an Increased Risk of Treated End‐Stage Renal Disease (2003) (18)
Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial (2016) (17)
Human Immunodeficiency Virus Infection in Hemodialysis Patients (1988) (17)
Potassium, Blood Pressure, and Cardiovascular Disease: An Epidemiologic Perspective (1997) (17)
Blood pressure response to potassium supplementation is associated with genetic variation in endothelin 1 and interactions with E selectin in rural Chinese (2010) (17)
Hypertension Control Among Newly Treated Patients Before and After Publication of the Main ALLHAT Results and JNC 7 Guidelines (2012) (16)
Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. (2016) (16)
Adherence to low‐carbohydrate and low‐fat diets in relation to weight loss and cardiovascular risk factors (2016) (16)
Analgesics and chronic renal disease. (1996) (16)
Plasma levels and hepatic extraction of renin and aldosterone in alcoholic liver disease. (1979) (16)
Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians (2019) (16)
Comparing the SPRINT and the HOPE-3 Blood Pressure Trial. (2016) (16)
Relationships Between Selected Gene Polymorphisms and Blood Pressure Sensitivity to Weight Loss in Elderly Persons With Hypertension (2013) (16)
Factors associated with high density lipoprotein cholesterol in Japanese and American telephone executives. (1991) (15)
The Glycemic Effects of Antihypertensive Medications (2013) (15)
Physician knowledge of the CAGE alcohol screening questions and its impact on practice. (1994) (15)
Baseline characteristics of randomized participants in the trial of nonpharmacologic intervention in the elderly (TONE) (1997) (15)
Genome-Wide Linkage and Positional Candidate Gene Study of Blood Pressure Response to Dietary Potassium Intervention: The Genetic Epidemiology Network of Salt Sensitivity Study (2010) (15)
Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients. (1993) (15)
Estimated Impact of Achieving Optimal Cardiovascular Health Among US Adults on Cardiovascular Disease Events (2021) (14)
Renal vein renin activity: a prospective study of sampling techniques and methods of interpretation. (1977) (14)
Sodium and Potassium Intake in US Adults (2018) (14)
Validation Status of Blood Pressure Measuring Devices Sold Globally. (2022) (14)
Sodium and cardiovascular disease: what the data show. (2014) (14)
Aligning Adult and Pediatric Blood Pressure Guidelines. (2019) (13)
Experimental approaches to determining the choice of first-step therapy for patients with hypertension. The ALLHAT Research Group Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. (1996) (13)
OR-2: Risk and impact of incident glucose disorders in hypertensive older adults treated with an ace inhibitor, a diuretic, or a calcium channel blocker: a report from the allhat trial (2004) (13)
Treatment-Resistant Hypertension and Outcomes Based on Randomized Treatment Group in ALLHAT. (2017) (13)
Evidence for the Universal Blood Pressure Goal of <130/80 mm Hg Is Strong: Controversies in Hypertension - Pro Side of the Argument. (2020) (13)
Genetic variants in the renin–angiotensin system and blood pressure reactions to the cold pressor test (2010) (12)
Sodium, blood pressure, and cardiovascular disease: a compelling scientific case for improving the health of the public. (2014) (12)
Reprint of: Prevention and Control of Hypertension: JACC Health Promotion Series. (2018) (12)
A Review of the First Year of Medicare Coverage of Erythropoietin (1994) (12)
METABOLIC SYNDROME AND RISK OF CHRONIC KIDNEY DISEASE IN US ADULTS: P 170 (2004) (12)
Therapeutic lifestyle changes and drug treatment for high blood cholesterol in China and application of the Adult Treatment Panel III guidelines. (2005) (12)
Left ventricular hypertrophy and skin color among American blacks. (1991) (12)
Flawed evidence should not derail sound policy: the case remains strong for population-wide sodium reduction. (2013) (11)
Primary prevention of hypertension: rationale, approaches, realities and perspectives. (1996) (11)
Agreement of Blood Pressure Measurements Between Random-Zero and Standard Mercury Sphygmomanometers (2008) (11)
Weight change and mortality: Long‐term results from the trials of hypertension prevention (2018) (11)
Erratum to: Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA) (2012) (11)
2022 World Hypertension League, Resolve To Save Lives and International Society of Hypertension dietary sodium (salt) global call to action (2022) (11)
HEARTS in the Americas: a global example of using clinically validated automated blood pressure devices in cardiovascular disease prevention and management in primary health care settings (2022) (11)
Community cholesterol screening. Impact of labeling on participant behavior. (1990) (10)
Maternal history of hypertension and blood pressure response to potassium intake: the GenSalt Study. (2012) (10)
Effect of Intensive and Standard Clinic‐Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT (2019) (10)
Sodium Intake and Risk of Hypertension: A Systematic Review and Dose–Response Meta-analysis of Observational Cohort Studies (2022) (10)
Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals. (2019) (10)
Treatment of Hypertension: A Review. (2022) (10)
Risk Factors for Low Pharmacy Refill Adherence Among Older Hypertensive Men and Women by Race (2018) (9)
Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial) (2018) (9)
Association between blood pressure responses to the cold pressor test and dietary sodium intervention in a Chinese population. (2008) (9)
Cardiovascular Disease Prevention and Implications of Coronavirus Disease 2019: An Evolving Case Study in the Crescent City (2020) (9)
Dietary sodium chloride (salt), other dietary components and blood pressure: paradigm expansion, not paradigm shift. (2000) (9)
Effect of Serum Adiponectin Levels on the Association Between Childhood Body Mass Index and Adulthood Carotid Intima-Media Thickness. (2017) (9)
Association between chronic kidney disease and cancer mortality: A report from the ALLHAT. (2017) (9)
Immunity-to-Change: Are Hidden Motives Underlying Patient Nonadherence to Chronic Disease Medications? (2014) (9)
[2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the AmericasDiretrizes de 2021 da Organização Mundial da Saúde sobre o tratamento medicamentoso da hipertensão arterial: repercussões para as políticas na região das Américas (2022) (9)
Risk factors for hypercreatinemia in patients with systemic lupus erythematosus (1999) (9)
Hypertension in Chronic Renal Failure (1983) (9)
Calcium channel blockade in dialysis patients with left ventricular hypertrophy and well-preserved systolic function. (1987) (9)
Epidemiology of clinical medicine. (2000) (9)
Evidence Supporting the Blood Pressure Treatment Goal of Less Than 130/80 mm Hg. (2019) (9)
Variation in Genes that Regulate Blood Pressure Are Associated with Glomerular Filtration Rate in Chinese (2014) (9)
Effect of age and gender on kidney function in renal transplant donors: a prospective study. (1993) (9)
A hybrid 4-item Krousel-Wood Medication Adherence Scale predicts cardiovascular events in older hypertensive adults. (2019) (9)
Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). (2020) (9)
Proportion of US Adults Recommended Out-of-Clinic Blood Pressure Monitoring According to the 2017 Hypertension Clinical Practice Guidelines. (2019) (9)
Clinical Trial Design Principles and Outcomes Definitions for Device-Based Therapies for Hypertension: A Consensus Document From the Hypertension Academic Research Consortium (2022) (8)
Guideline-Driven Management of Hypertension (2021) (8)
Etiologic Factors in Renovascular Fibromuscular Dysplasia (2005) (8)
Childhood Risk Factors and Pregnancy-Induced Hypertension: The Bogalusa Heart Study. (2016) (8)
Recent trends in the epidemiology of stroke: what accounts for the persistent decline in stroke mortality in Western nations? (1987) (8)
Patient Selection for Intensive Blood Pressure Management Based on Benefit and Adverse Events. (2021) (8)
Chapter 2 – Blood Pressure in Westernized and Isolated Populations (2007) (8)
Blood Pressure Management in Stroke. (2020) (8)
Preventing the Next Pandemic: The Case for Investing in Circulatory Health – A Global Coalition for Circulatory Health Position Paper (2021) (8)
2021 World Health Organization guideline on pharmacological treatment of hypertension: Policy implications for the region of the Americas (2022) (8)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. (2022) (7)
The Effects of eGFR Change on CVD, Renal, and Mortality Outcomes in a Hypertensive Cohort Treated With 3 Different Antihypertensive Medications (2018) (7)
Influence of renin levels on the treatment of essential hypertension with thiazide diuretics. (1987) (7)
Evolution of Blood Pressure Clinical Practice Guidelines: A Personal Perspective. (2019) (7)
Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis (2022) (7)
New findings bearing on the prevention, detection and management of high blood pressure (2021) (7)
Experiences and Beliefs of Low‐Income Patients With Hypertension in Louisiana and Mississippi During the COVID‐19 Pandemic (2020) (7)
Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control: A Secondary Analysis of a Randomized Clinical Trial. (2022) (7)
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD. (2022) (7)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines (2022) (7)
Is It Time to Employ a Measure of Visit-to-Visit Variability in Clinical Practice? (2017) (6)
More on dietary sodium and blood pressure. (1997) (6)
Strategies for prevention of cardiovascular disease in adults with hypertension (2020) (6)
Renovascular hypertension: comparison of medical and surgical therapy. (1979) (6)
Dietary Sodium Intake: Scientific Basis for Public Policy (2015) (6)
Dietary Fiber Intake and Reduced Risk of Coronary Heart Disease in US Men and Women (2001) (6)
Relationship Between Birth Weight and the Double Product in Childhood, Adolescence, and Adulthood (from the Bogalusa Heart Study). (2017) (6)
Forgotten kidney: asynchronous bilateral ureteropelvic junction obstruction. (1978) (6)
Body Weight, Sodium, Potassium, and Blood Pressure (2015) (6)
Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9. (2006) (6)
Renal venous renin sampling. Prospective study of technique and methods. (1981) (5)
Writing a Trustworthy Hypertension Guideline. (2019) (5)
Hyponatremia in the general population. What does it mean? (2016) (5)
A hybrid 4-item Krousel-Wood Medication Adherence Scale predicts cardiovascular events in older hypertensive adults. (2019) (5)
Rapid eGFR change as a determinant of cardiovascular and renal disease outcomes and of mortality in hypertensive adults with and without type 2 diabetes. (2018) (5)
The evolving epidemic of cardiovascular and renal diseases: a worldwide challenge. (1995) (5)
Potassium in cardiovascular and renal medicine : arrhythmias, myocardial infarction, and hypertension (1986) (5)
Essential hypertension--therapeutic implications of epidemiological risk estimation. (1984) (5)
Polymorphisms in the GNB3 and ADD1 genes and blood pressure in a Chinese population (2010) (5)
Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial (2017) (5)
Sprinting Toward the Optimal Blood Pressure Target for Hypertensive Patients. (2018) (5)
Does renin angiotensin system blockade deserve preferred status over other anti-hypertensive medications for the treatment of people with diabetes? (2016) (5)
SOYBEAN PROTEIN SUPPLEMENTATION AND BLOOD PRESSURE: A RANDOMIZED, CONTROLLED CLINICAL TRIAL (2004) (4)
Diet supplementation with fish oils and blood pressure reduction: A meta- analysis (1994) (4)
Dietary sodium and blood pressure. (1996) (4)
Cardiovascular risk factor levels in urban and rural Thailand – results from the International Collaborative Study of Cardiovascular Disease in Asia (2003) (4)
Hormonal responses to acute volume changes in anephric subjects. (1983) (4)
Blood pressure intervention and control in the systolic blood pressure intervention trial (SPRINT) (2016) (4)
Renovascular hypertension: results of medical and surgical therapy. (1981) (4)
Response by Beddhu et al to Letters Regarding Article, "Influence of Baseline Diastolic Blood Pressure on Effects of Intensive Compared With Standard Blood Pressure Control". (2018) (4)
A Randomized Trial of Intensive versus Standard Blood-Pressure Control. (2016) (4)
SPRINT Revisited: Updated Results and Implications. (2021) (3)
Baseline Diastolic Blood Pressure and Cardiovascular Outcomes in SPRINT Participants with Chronic Kidney Disease. (2020) (3)
Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial (2020) (3)
Response to letter regarding article, "lower levels of sodium intake and reduced cardiovascular risk". (2014) (3)
Real‐World Evidence Supports Optimally Dosed Thiazide‐Type Diuretics As Preferred in Treatment Regimens of Older Adults with Hypertension (2015) (3)
An association between the renin angiotensin system, blood pressure and potassium intake. (1980) (3)
The epidemiology of hypertension‐related renal disease (1993) (3)
The urgency to regulate validation of automated blood pressure measuring devices: a policy statement and call to action from the world hypertension league (2022) (3)
Global proliferation and clinical consequences of non-validated automated BP devices (2022) (3)
Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age (2021) (3)
Dietary sodium intake and incidence of congestive heart failure in overweight U.S. men and women: NHANES I epidemiologic follow-up study (NHEFS) (2000) (3)
Prevention of Blood Pressure‐related Kidney Failure: An Epidemiological Perspective (1993) (3)
ASPIRIN AND THE RISK OF HEMORRHAGIC STROKE (1999) (3)
Diuretics and Arrhythmias in the Medical Research Council Trial (1984) (3)
Atrial Fibrillation and the Risk of Early‐Onset Dementia: A Systematic Review and Meta‐Analysis (2022) (3)
Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. (2022) (3)
Temporal trends in atherosclerotic cardiovascular disease risk among U.S. adults. Analysis of the National Health and Nutrition Examination Survey (NHANES), 1999-2018. (2022) (3)
Safety vs Efficacy of Lowering Blood Pressure-Reply. (2017) (3)
Potential Implications of the Systolic Blood Pressure Intervention Trial in Korea. (2016) (3)
Cardiovascular Disease Risk Estimation in China (2019) (3)
Packages of sodium (Salt) sold for consumption and salt dispensers should be required to have a front of package health warning label: A position statement of the World Hypertension League, national and international health and scientific organizations (2019) (3)
PREVALENCE OF OVERWEIGHT AND OBESITY IN CHINA: THE INTERNATIONAL COLLABORATIVE STUDY OF CARDIOVASCULAR DISEASE IN ASIA (INTERASIA) (2004) (2)
Influence of prediabetes on the effects of intensive systolic blood pressure control on kidney events. (2019) (2)
Epidemiology and prevention. (1997) (2)
Guidelines for Home Blood Pressure Monitoring (2019) (2)
Blood Pressure and Serum Creatinine-Reply (1993) (2)
Chapter 30 – Initial Evaluation and Approach to the Patient with Hypertension (2007) (2)
Metabolic Syndrome and Salt-Sensitivity of Blood Pressure among Persons without Diabetes (2010) (2)
Thiazide-Induced Dysglycemia (2008) (2)
Joint modeling of systolic blood pressure and the primary outcome in Systolic Blood Pressure Intervention Trial. (2019) (2)
Blood pressure targets. (2017) (2)
Salt, Blood Pressure, and Cointervention-Reply (1997) (2)
Academic medicine and managed care: seeking common ground. (1999) (2)
Coronary atherosclerosis across the continuum of blood pressure. (2021) (2)
Abstract 35: Estimated Impact of Achieving Optimal Cardiovascular Health in the US Adult Population on Cardiovascular Disease Events (2020) (2)
K17 The use of a reduced sodium salt containing potassium and magnesium as an anjunctive approach to treatment of hypertension with antihypertensive medications (1997) (2)
Postural hand tremor and incident hypertension in young to middle-aged adults: the Bogalusa heart study (2016) (2)
Lessons learned from Systolic Blood Pressure Intervention Trial (2017) (2)
Effect of Intensive versus Standard BP Control on AKI and Subsequent Cardiovascular Outcomes and Mortality: Findings from the SPRINT EHR Study (2022) (2)
Latest News in Hypertension Management (2)
Association between population hypertension control and ischemic heart disease and stroke mortality in 36 countries of the Americas, 1990-2019: an ecological study (2022) (2)
The importance of renin in post-transplantation (single-kidney) hypertension. (1976) (2)
Patient characteristics related to intensity of weight reduction care in a university medical clinic (1992) (1)
Response to "The data show a U-shaped association of sodium intake with cardiovascular disease and mortality". (2015) (1)
Chlorthalidone and Hydrochlorothiazide for Treatment of Patients With Hypertension. (2020) (1)
Mild Hypertension: Is It important? (1981) (1)
Hypertension, cerebrovascular disease and stomach cancer: is the salt hypothesis true? (1981) (1)
SERUM CREATININE LEVELS IN THE CHINESE POPULATION: THE INTERNATIONAL COLLABORATIVE STUDY OF CARDIOVASCULAR DISEASE IN ASIA (2004) (1)
Hypertension in chronic renal failure. Clinical presentation, prognosis, pathophysiology and treatment. (1983) (1)
Effect of Dietary Protein Supplementation on Blood Pressure (2011) (1)
International Consensus on Standardized Clinic Blood Pressure Measurement - A Call to Action. (2023) (1)
The Glycemic Consequences of Antihypertensive Medications (2015) (1)
Prognostic relevance of visit‐to‐visit office blood pressure variability in Systolic Blood Pressure Intervention Trial: Same data, different conclusions? (2018) (1)
Hypertension as an Important Public Health Challenge (2003) (1)
Analgesia and public health: meeting the global challenges. (2002) (1)
What If Chlorthalidone-Associated Hyperglycemia Develops?—Reply (2007) (1)
Visit-to-visit variability of blood pressure and coronary heart disease, stroke, heart failure and mortality: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) (2014) (1)
Diuretic-induced cardiac arrhythmias. (1983) (1)
154 HYPERTENSION IN COAPTATION OF THE AORTA: THE ROLE OF THE RENIN-ANGIOTENSIN SYSTEM (1978) (1)
American Heart Association Sodium Reduction Recommendations Sodium, Blood Pressure, and Cardiovascular Disease : Further Evidence Supporting the (2012) (1)
19A Challenge of minority recruitment in clinical trials: Experience of the African American study of kidney disease and hypertension (AASK) pilot study (1995) (1)
Age-specific prevalence and factors associated with normal blood pressure among US adults. (2021) (1)
Beyond reform: Catholic health care matters even when all can pay. Access is just one dimension of the ministry's distinctive mission. (2009) (1)
SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE. (2016) (1)
ORIGINAL INVESTIGATIONS Creatinine Clearance as a Measure of GFR in Screenees for the African-American Study of Kidney Disease and Hypertension Pilot Study (1998) (1)
Blood Pressure Intervention and Control in SPRINT (2022) (1)
Comparing Low-Fat and Low-Carbohydrate Diets (2014) (1)
Hypertension in diabetes mellitus. (2009) (1)
Abstract P171: Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability: Systolic Blood Pressure Intervention Trial (SPRINT) (2019) (1)
Weak research on dietary sodium should not generate strong conclusions on a major public health policy (2023) (1)
Genetic variants in the ADD1 and GNB3 genes and blood pressure response to potassium supplementation (2010) (1)
Implementation of Multifaceted Patient-Centered Treatment Strategies for Intensive Blood Pressure Control (IMPACTS): Rationale and design of a cluster-randomized trial☆☆☆ (2020) (1)
Reflections on the U.S. preventive services task force recommendations for screening for hypertension and hypercholesterolemia (1990) (1)
CARDIOVASCULAR DISEASE The Correspondence between Coronary Heart Disease Mortality and Risk Factor Prevalence among States in the United States , 1991-1992 (2002) (1)
Abstract MP26: Adherence to Low Carbohydrate and Low Fat Diets in Relation to Weight Loss and Cardiovascular Risk Factor Reduction (2015) (0)
Comment on: Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the united states? A hypothesis. by Hawkins RG et al (2006) (0)
Hypertension in diabetes mellitus. (2009) (0)
Abstract P244: Urinary Triclosan Concentrations Are Associated with Body Mass Index and Waist Circumference in US Population, NHANES 2003-2010 (2014) (0)
Dietary Vitamin E Intake and Risk of Coronary Heart Disease in a Representative Sample of US Adults: NHANES I Epidemiologic Follow-up Study (2001) (0)
421 ANALYSIS OF SEX HORMONE GENES REVEALS GENDER DIFFERENCES IN THE GENETIC ETIOLOGY OF BLOOD PRESSURE SALT-SENSITIVITY: THE GENSALT STUDY (2012) (0)
Epidemiological Considerations in the Treatment of Hypertension (2012) (0)
Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study 1–3 (2002) (0)
The World Hypertension League becomes a partner of the Journal of Human Hypertension (2021) (0)
Blood Pressure and Skin Color-Reply (1991) (0)
Treatment to Prevent Heart Attack Trial : Results by Sex Mortality and Morbidity During and After Antihypertensive and Lipid-Lowering (2013) (0)
Detection, Treatment and Control of Hypertension in the General Population (2005) (0)
Challenges and evolving contributions of epidemiology in nephrology and hypertension. (1996) (0)
Abstract 3942: Blood Pressure Response to Cold Pressor Predicts Salt-Sensitivity in the GenSalt Study (2006) (0)
Early Decline in Kidney Function With Intensive Systolic Blood Pressure Lowering: Does It Matter? (2020) (0)
Correction to: Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial (2021) (0)
Annual Congress of the Chinese Blood Purification Center Administration Committee. September 25-28, 2014, Guangzhou: Abstracts (2015) (0)
Relation Between Renin Release and Blood Pressure Response to Nonsteroidal Anti‐inflammatory Drugs in Hypertensioniologic Factors in Renovascular Fibromuscular Dysplasia A Case‐Control Study (1989) (0)
What if chlorthalidone-associated hyperglycemia develops? Authors' reply (2007) (0)
hypertension prevention ( TOHP ) observational follow-up of the trials of on cardiovascular disease outcomes : Long term effects of dietary sodium reduction (2007) (0)
SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE (2016) (0)
Abstract 5138: Effect of Dietary Protein Supplementation on Blood Pressure: A Randomized Controlled Trial (2008) (0)
Prevalence and outcomes of low ankle brachial index by atherosclerotic cardiovascular disease risk level: Insights from the National Health and Nutrition Examination Survey (NHANES). (2022) (0)
Follow-Up of the Tohp Randomized Sodium Reduction Interventions for Subsequent Cardiovascular Disease and Mortality (2006) (0)
MORE ON DIETARY SODIUM AND BLOOD PRESSURE. AUTHORS' REPLY (1997) (0)
Availability, Cost, and Consumer Ratings of Popular Nonvalidated vs Validated Blood Pressure-Measuring Devices Sold Online in 10 Countries. (2023) (0)
JS-WHL-ISH-RTSL-3: IS THE CURRENT RECOMMENDATION BY GUIDELINES FOR HYPERTENSION TO KEEP DAILY SODIUM INTAKE BELOW 5 G (SODIUM 2300 MG) REALISTIC? (2023) (0)
Abstract 20: Effect of Dietary Sodium Reduction in Chronic Kidney Disease Patients With Albuminuria: Results of a Randomized Trial (2023) (0)
Abstract 38: A Novel Two-Question Antihypertensive Medication Adherence Scale Predicts Blood Pressure Control and Cardiovascular Disease Outcomes (2023) (0)
Abstract P413: Do Methodological Issues Account for the Inconsistent Results Observed in Cohort Studies of Sodium Intake and Clinical Cardiovascular Disease Outcomes? (2013) (0)
How common is hypertension in the very old? Incidence, prevalence, prognosis, and co-morbidity (2022) (0)
Effect of Dietary Sodium and Potassium Intervention on Blood Glucose (2010) (0)
Response by Filippini et al to Letter Regarding Article, "Blood Pressure Effects of Sodium Reduction: Dose-Response Meta-Analysis of Experimental Studies". (2021) (0)
New wrinkles in hypertension management 2022 (2022) (0)
African Control of Hypertension through Innovative Epidemiology and a Vibrant Ecosystem (ACHIEVE): novel strategies for accelerating hypertension control in Africa. (2023) (0)
Blood Pressure and the Kidney: How Low Should It Be? (1995) (0)
THE EGYPTIAN JOURNAL OF HYPERTENSION AND CARDIOVASCULAR RISK (2008) (0)
Abstract P205: Potential Impact of the 2014 High Blood Pressure Guideline on Adults in China and the US (2015) (0)
Abstract 06: Body Mass Index Growth Trajectories During Childhood and Adult Obesity Risk (2017) (0)
The Costs of Antihypertensive Therapy-Reply (1996) (0)
Abstract P232: Common Variants of the Estrogen Receptor 1 Gene Predict Decreased Blood Pressure Salt-Sensitivity in Men: The GenSalt Study (2012) (0)
Abstract P097: Trajectories of Childhood Blood Pressure and Adult Left Ventricular Hypertrophy: The Bogalusa Heart Study (2018) (0)
Risk-benefit profile of intensive blood pressure treatment - Authors' reply. (2018) (0)
中国心力衰竭流行病学调查及其患病率 (2003) (0)
Angiotensin-converting enzyme inhibitors and diuretics: Optimal combination therapy [8] (multiple letters) (2004) (0)
Abstract P451: Coronary Artery Calcium and the Association Between Dietary Fish Intake and Atherosclerotic Cardiovascular Disease Risk (2023) (0)
09A Assessing medication adherence in the African American study of kidney disease and hypertension (AASK) pilot study (1995) (0)
Reply. (2021) (0)
[Comparative study between prazosin and methyldopa in essential arterial hypertension: results of a parallel, randomized double-blind trial]. (1980) (0)
Abstract P172: Postural Hand Tremor and Incident Hypertension in Young-to-middle Aged Adults: The Bogalusa Heart Study (2016) (0)
Vision Screening in a Primary Care Setting (2016) (0)
P6365Contrasting the impact of the European (ESC/ESH 2018) versus American (ACC/AHA 2017) high blood pressure clinical practice guidelines in Poland (2019) (0)
Comparison of Prazosin and Methyldopa in Essential Hypertension: Results of a Randomized, Double‐Blind, Parallel Trial (1979) (0)
DIETARY FIBER SUPPLEMENTATION AND CARDIOVASCULAR RISK FACTORS: A RANDOMIZED CROSSOVER TRIAL (2004) (0)
Treatment: special conditions. Prevention/public health strategies. (2015) (0)
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and MortalityA Systematic Review and Network Meta-analysis (2017) (0)
Costs and benefits of echocardiography strategies after stroke (1998) (0)
Intensive Blood Pressure Treatment Goals: evidence for cardiovascular protection from observational studies and clinical trials. (2022) (0)
Renovascular hypertension: Treatment by balloon catheter dilatation (1979) (0)
AW-AD-6: PREVALENCE OF VALIDATED BLOOD PRESSURE MEASURING DEVICES BEING SOLD BY AMAZON: 12-MONTH PROSPECTIVE ANALYSIS ACROSS 10 COUNTRIES (2023) (0)
Body weight and mortality among adults in China (2007) (0)
Severe methicillin-induced renal failure treated with hemodialysis. (1978) (0)
Abstract 047: Clinical Outcomes by Race and Ethnicity in the Systolic Blood Pressure Intervention Trials (SPRINT): A Randomized Control Trial (2017) (0)
DISTRESS OVER THE NONEFFECT OF STRESS. AUTHORS' REPLY (1992) (0)
Distress Over the Noneffect of Stress-Reply (1992) (0)
Reprint of: Prevention and Control of Hypertension (0)
Public health professionals and interpersonal violence. (1997) (0)
How to Improve Awareness, Treatment, and Control of Hypertension in Africa, and How to Reduce Its Consequences. A Call to Action From the World Hypertension League. (2022) (0)
Concordance between clinical outcomes in the systolic blood pressure intervention trial and in the electronic health record. (2023) (0)
The Sky Raiders (2019) (0)
Renovascular hypertension: Does intravenous furosemide enhance renal venous renin ratios and differences? (1979) (0)
Isolated systolic hypertension and seven-year risk of age-related posterior subcapsular cataract extraction: a population-based, prospective study (1997) (0)
S-06-5: HYPERTENSION MANAGEMENT IN PATIENTS WITH CARDIOVASCULAR DISEASE (2023) (0)
Sodium, Blood Pressure, and Cardiovascular Disease. (2021) (0)
983 MATERNAL HISTORY OF HYPERTENSION PREDICTS BLOOD PRESSURE RESPONSE TO POTASSIUM INTAKE: THE GENSALT STUDY (2012) (0)
Abstract 15512: Sodium Intake and All-Ccuse Mortality Over 20 Years of Follow-up (2015) (0)
Effect of Soy Protein Supplementation on Serum Lipids: (2001) (0)
The Power of Cac Coronary Artery Calcium and Primary Prevention Risk Assessment: What Is the Evidence? an Updated Meta-analysis on Patient and Physician Behavior Cardiovascular Perspective (0)
The roles of sodium, potassium and calcium in the treatment of hypertension (2002) (0)
Abstract 100: Hip and Pelvic Fracture Risk in Adults Treated with Three Different Classes of Antihypertensive Medications: The ALLHAT Study (2016) (0)
Blood Pressure and Risk of Cardiovascular Disease in Chinese Men and Women. Commentary (2008) (0)
Abstract 16242: Weight Sensitivity in Hypertension (2012) (0)
Multiple cysts in chronic renal disease. (1984) (0)
Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease andMortality (2017) (0)
The following is in reply: To the editor (1989) (0)
Oral Potassium Reduces Blood Pressure (1997) (0)
Correction to: African Control of Hypertension through Innovative Epidemiology and a Vibrant Ecosystem (ACHIEVE): novel strategies for accelerating hypertension control in Africa. (2023) (0)

This paper list is powered by the following services:

Other Resources About Paul Whelton

en.wikipedia.org

What Schools Are Affiliated With Paul Whelton?

Paul Whelton is affiliated with the following schools:

Paul Whelton's Academic­Influence.com Rankings

Why Is Paul Whelton Influential?

Paul Whelton's Published Works

Published Works

Other Resources About Paul Whelton

What Schools Are Affiliated With Paul Whelton?

Paul Whelton's AcademicInfluence.com Rankings